These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9107362)

  • 1. Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies.
    Konstantinov SM; Kaminsky R; Brun R; Berger MR; Zillmann U
    Acta Trop; 1997 Apr; 64(3-4):145-54. PubMed ID: 9107362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
    Croft SL; Snowdon D; Yardley V
    J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.
    Zeisig R; Jungmann S; Arndt D; Schütt A; Nissen E
    Anticancer Drugs; 1993 Feb; 4(1):57-64. PubMed ID: 8457716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations.
    Papagiannaros A; Bories C; Demetzos C; Loiseau PM
    Biomed Pharmacother; 2005 Dec; 59(10):545-50. PubMed ID: 16325367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133.
    Stekar J; Hilgard P; Voegeli R; Maurer HR; Engel J; Kutscher B; Nössner G; Schumacher W
    Cancer Chemother Pharmacol; 1993; 32(6):437-44. PubMed ID: 8258191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
    Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
    Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on lipidomimetic derivatives of alpha-difluoromethylornithine (DFMO) to enhance the bioavailability in a Trypanosoma B. brucei murine trypanosomiasis model.
    Loiseau PM; Czok M; Chauffert O; Bourass J; Letourneux Y
    Parasite; 1998 Sep; 5(3):239-46. PubMed ID: 9772723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei.
    Demey F
    Vet Res Commun; 1987; 11(3):271-4. PubMed ID: 2442883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.
    Fichtner I; Zeisig R; Naundorf H; Jungmann S; Arndt D; Asongwe G; Double JA; Bibby MC
    Breast Cancer Res Treat; 1994; 32(3):269-79. PubMed ID: 7865855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):135-8. PubMed ID: 1654590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of spiroarsoranes on Trypanosoma brucei brucei and T. b. rhodesiense.
    Loiseau PM; Jennings FW; Lubert P; Wolf JG
    Parasitol Res; 1996; 82(5):477-80. PubMed ID: 8738290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bistacrines as potential antitrypanosomal agents.
    Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
    Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations.
    Zeisig R; Fichtner I; Arndt D; Jungmann S
    Anticancer Drugs; 1991 Aug; 2(4):411-7. PubMed ID: 1797199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of verapamil alone and in combination with trypanocides on multidrug-resistant Trypanosoma brucei brucei.
    Kaminsky R; Zweygarth E
    Acta Trop; 1991 Aug; 49(3):215-25. PubMed ID: 1685302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
    Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Masuma R; Shiomi K; Takahashi Y; Ichimura M; Yamada H; Omura S
    J Antibiot (Tokyo); 2008 Oct; 61(10):627-32. PubMed ID: 19168977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylphosphocholines: a new class of membrane-active anticancer agents.
    Hilgard P; Klenner T; Stekar J; Unger C
    Cancer Chemother Pharmacol; 1993; 32(2):90-5. PubMed ID: 8485813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.